DE69310567T2 - In der 3-Position durch einen gesättigten oder ungesättigten Fettsäurerest substituierte Pyrrolidinderivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel mit Thromboxan-A2 inhibierender Aktivität - Google Patents
In der 3-Position durch einen gesättigten oder ungesättigten Fettsäurerest substituierte Pyrrolidinderivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel mit Thromboxan-A2 inhibierender AktivitätInfo
- Publication number
- DE69310567T2 DE69310567T2 DE69310567T DE69310567T DE69310567T2 DE 69310567 T2 DE69310567 T2 DE 69310567T2 DE 69310567 T DE69310567 T DE 69310567T DE 69310567 T DE69310567 T DE 69310567T DE 69310567 T2 DE69310567 T2 DE 69310567T2
- Authority
- DE
- Germany
- Prior art keywords
- group
- optionally substituted
- thromboxane
- saturated
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
- C07D207/48—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9201523A FR2687146B1 (fr) | 1992-02-12 | 1992-02-12 | Nouveaux derives de pyrrolidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69310567D1 DE69310567D1 (de) | 1997-06-19 |
DE69310567T2 true DE69310567T2 (de) | 1997-12-18 |
Family
ID=9426530
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69310567T Expired - Fee Related DE69310567T2 (de) | 1992-02-12 | 1993-02-11 | In der 3-Position durch einen gesättigten oder ungesättigten Fettsäurerest substituierte Pyrrolidinderivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel mit Thromboxan-A2 inhibierender Aktivität |
Country Status (13)
Country | Link |
---|---|
US (2) | US5387591A (de) |
EP (1) | EP0556119B1 (de) |
JP (1) | JPH0739385B2 (de) |
AT (1) | ATE153016T1 (de) |
AU (1) | AU655868B2 (de) |
CA (1) | CA2089349C (de) |
DE (1) | DE69310567T2 (de) |
DK (1) | DK0556119T3 (de) |
ES (1) | ES2105145T3 (de) |
FR (1) | FR2687146B1 (de) |
GR (1) | GR3023932T3 (de) |
NZ (1) | NZ245884A (de) |
ZA (1) | ZA93996B (de) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2685325B1 (fr) * | 1991-12-20 | 1994-02-04 | Adir Cie | Nouveaux derives de pyrrolidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
FR2722194B1 (fr) * | 1994-07-06 | 1996-08-23 | Adir | Nouveaux derives de benzopyrane, leur procede de preparation et les compositions pharmacuetiques qui les contiennent |
JP4057088B2 (ja) * | 1996-04-22 | 2008-03-05 | 株式会社カネカ | ピロリジン誘導体の製造方法 |
JP2002504088A (ja) * | 1996-12-06 | 2002-02-05 | アボツト・ラボラトリーズ | ベンゾピラノピロール及びベンゾピラノピリジンアルファ−1アドレナリン作用性化合物 |
US5891882A (en) * | 1996-12-06 | 1999-04-06 | Abbott Laboratories | Benzopyranopyrrole and benzopyranopyridine α-1 adenergic compounds |
TWI274750B (en) | 1999-01-12 | 2007-03-01 | Abbott Gmbh & Co Kg | Triazole compounds showing high affinity to dopamine D3 receptor and pharmaceutical composition comprising the same |
GB0002100D0 (en) * | 2000-01-28 | 2000-03-22 | Novartis Ag | Organic compounds |
TW200302717A (en) * | 2002-02-06 | 2003-08-16 | Schering Corp | Novel gamma secretase inhibitors |
CN1859914A (zh) * | 2003-09-30 | 2006-11-08 | 默克公司 | 苯基吡咯烷醚速激肽受体拮抗剂 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL86173A (en) * | 1987-05-01 | 1992-02-16 | Fujisawa Pharmaceutical Co | Pyrrolidine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same |
JPH0798795B2 (ja) * | 1987-05-08 | 1995-10-25 | 塩野義製薬株式会社 | スルホンアミド置換不飽和脂肪酸 |
US5130323A (en) * | 1988-10-31 | 1992-07-14 | Fujisawa Pharmaceutical Co., Ltd. | Pyrrolidine derivatives |
US5128366A (en) * | 1990-07-05 | 1992-07-07 | Shinogi & Co., Ltd. | Pyrrole derivatives |
US5157128A (en) * | 1990-11-30 | 1992-10-20 | Warner-Lambert Company | Certain optically active substituted α,α-dialkyl-pyrrolidine-3-methamines useful as intermediates |
FR2685325B1 (fr) * | 1991-12-20 | 1994-02-04 | Adir Cie | Nouveaux derives de pyrrolidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
-
1992
- 1992-02-12 FR FR9201523A patent/FR2687146B1/fr not_active Expired - Fee Related
-
1993
- 1993-02-11 DK DK93400340.1T patent/DK0556119T3/da active
- 1993-02-11 DE DE69310567T patent/DE69310567T2/de not_active Expired - Fee Related
- 1993-02-11 US US08/016,501 patent/US5387591A/en not_active Expired - Fee Related
- 1993-02-11 NZ NZ245884A patent/NZ245884A/en unknown
- 1993-02-11 AT AT93400340T patent/ATE153016T1/de not_active IP Right Cessation
- 1993-02-11 AU AU33010/93A patent/AU655868B2/en not_active Ceased
- 1993-02-11 ES ES93400340T patent/ES2105145T3/es not_active Expired - Lifetime
- 1993-02-11 CA CA002089349A patent/CA2089349C/fr not_active Expired - Fee Related
- 1993-02-11 EP EP93400340A patent/EP0556119B1/de not_active Expired - Lifetime
- 1993-02-12 JP JP5024421A patent/JPH0739385B2/ja not_active Expired - Lifetime
- 1993-02-12 ZA ZA93996A patent/ZA93996B/xx unknown
-
1994
- 1994-06-14 US US08/259,697 patent/US5407946A/en not_active Expired - Fee Related
-
1997
- 1997-06-30 GR GR970401580T patent/GR3023932T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
FR2687146B1 (fr) | 1994-04-01 |
JPH0739385B2 (ja) | 1995-05-01 |
ES2105145T3 (es) | 1997-10-16 |
ZA93996B (en) | 1993-09-20 |
AU3301093A (en) | 1993-08-19 |
DK0556119T3 (da) | 1997-12-15 |
AU655868B2 (en) | 1995-01-12 |
GR3023932T3 (en) | 1997-09-30 |
NZ245884A (en) | 1994-11-25 |
CA2089349A1 (fr) | 1993-08-13 |
CA2089349C (fr) | 2001-10-16 |
DE69310567D1 (de) | 1997-06-19 |
EP0556119A1 (de) | 1993-08-18 |
EP0556119B1 (de) | 1997-05-14 |
FR2687146A1 (fr) | 1993-08-13 |
US5387591A (en) | 1995-02-07 |
ATE153016T1 (de) | 1997-05-15 |
US5407946A (en) | 1995-04-18 |
JPH069552A (ja) | 1994-01-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE132144T1 (de) | Chalkonderivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten | |
ATE28401T1 (de) | Naphthalen- oder azanaphthalencarbonsaeureamide als arzneimittel, naphthalen- oder azanaphthalencarbonsaeureamidderivate und verfahren zu ihrer herstellung. | |
DE69310567T2 (de) | In der 3-Position durch einen gesättigten oder ungesättigten Fettsäurerest substituierte Pyrrolidinderivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel mit Thromboxan-A2 inhibierender Aktivität | |
ATE224T1 (de) | 1,2-dihydro-chinolin-2-on-derivate, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel. | |
HU9401427D0 (en) | 19-nor steroide derivatives, process for producing them and compositions containing them | |
ATE107298T1 (de) | 3-aminochroman-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
ES8605796A1 (es) | Procedimiento de preparacion de nuevos derivados de la quinoleina y sus sales de adicion con acidos apropiados | |
GR3030234T3 (en) | 4-Phenylcarbamoyl-3-isoxazolecarboxylic acid derivatives with antiinflammatory activity | |
ATE3149T1 (de) | Isatinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
DE3889741D1 (de) | Substituierte 3H-Indole, Verfahren zu ihrer Herstellung sowie Arzneimittel. | |
CA2085570A1 (fr) | Nouveaux derives de pyrrolidine , leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
ATE124685T1 (de) | 4-phenylmethyl-1h-indol-derivate, verfahren und zwischenverbindungen zu deren herstellung, anwendung als arzneimittel und diese enthaltende zusammensetzungen. | |
DE58904867D1 (de) | Sulfonamidoalkyl-cyclohexan-verbindungen, verfahren zu ihrer herstellung sowie arzneimittel. | |
ATE86624T1 (de) | 17-aza-20,21-dinoreburnameninderivate, verfahren und zwischenprodukte zu ihrer herstellung, ihre anwendung als arzneimittel und diese enthaltende zubereitungen. | |
DE3863214D1 (de) | Glutaminsaeurederivate, ihre salze, verfahren zu ihrer herstellung, verwendung als arzneimittel und diese enthaltende zusammensetzungen. | |
ZA922625B (en) | Use of 2-iminothiazolidin-4-one derivatives as novel pharmaceutical active ingredients | |
ATE20063T1 (de) | 3-pyridyl-5-alkoxy(oder phenoxy- oder aralkyloxy- )pyrazol-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel. | |
DE69103271T2 (de) | Benzothiazolinderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel. | |
ATE94878T1 (de) | Imidazobenzodiazepine und ihre saeureadditionssalze, verfahren und zwischenprodukte zu ihrer herstellung, ihre verwendung als arzneimittel und diese enthaltende zubereitungen. | |
IE810080L (en) | Triazolobenzopyrans | |
ES8305304A1 (es) | "procedimiento de preparacion de derivados de etanolamina". | |
ATE9896T1 (de) | Substituierte 3-aryl-2-cycloalken-1-one, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel. | |
ES484246A1 (es) | Procedimiento de preparacion de nuevos derivados de ortoclo-robenzoil-2-cloro-4 glicilanilidas | |
ES478502A1 (es) | Un procedimiento para la preparacion de nuevas n-(piridotie-nopirazol)amidas | |
DE68903893T2 (de) | 20,21-dinoreburnamenin-derivate, substituiert in position 15 durch eine aminogruppe und deren salze, verfahren zu deren herstellung und die auf diese weise erhaltenen zwischenverbindungen, deren anwendung als arzneimittel und diese enthaltende pharmazeutische zusammensetzungen. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8327 | Change in the person/name/address of the patent owner |
Owner name: LES LABORATOIRES SERVIER, NEUILLY SUR SEINE, FR |
|
8339 | Ceased/non-payment of the annual fee |